Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2019

20.10.2018

Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han

verfasst von: Hairong Zhou, Yanjuan Che, Xiuhua Fu, Hong Wei, Xiuying Gao, Yanxuan Chen, Shaopeng Zhang

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

To investigate the association of single nucleotide polymorphisms (SNPs) within tissue factor pathway inhibitor-2 (TFPI-2) gene polymorphisms and additional gene–environment interaction with coronary atherosclerosis risk. Generalized multifactor dimensionality reduction (GMDR) was used to screen the best interaction combination among 4 SNPs, smoking and alcohol drinking. Logistic regression was performed to investigate association between 4 SNPs within TFPI-2 gene and coronary atherosclerosis risk. Coronary atherosclerosis risk was significantly higher in carriers with the A allele of rs34489123 within TFPI-2 gene than those with GG genotype (GA+AA versus GG), adjusted OR (95% CI) = 1.70 (1.20–2.31), and was also higher in carriers with the G allele of rs4264 within TFPI-2 gene than those with AA genotype (AG+GG versus AA), adjusted OR (95% CI) = 1.62 (1.21–2.11). GMDR model shown the best models for gene–environment interaction were rs34489123 and smoking after adjusting the covariates, which scored 10 out of 10 for cross-validation consistency and 0.0010 for the sign test. Heavy LD was found for SNPs rs34489123 and rs59805398 (D’ value was more than 0.8). Compared to control individuals, the AG haplotypes appeared to be significantly associated with increased coronary atherosclerosis risk, OR (95% CI) = 1.73 (1.22–2.32). We found that the A allele of rs34489123 and the G allele of rs4264 within TFPI-2 gene, interaction between rs34489123 and smoking and AG haplotypes were all associated with increased coronary atherosclerosis risk.
Literatur
2.
Zurück zum Zitat Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):SIII–S27 Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):SIII–S27
3.
Zurück zum Zitat Hansson GK, Robertson AK, Söderberg–Nauclér C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297–329CrossRefPubMed Hansson GK, Robertson AK, Söderberg–Nauclér C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297–329CrossRefPubMed
4.
Zurück zum Zitat Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U (1989) Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579–592CrossRefPubMed Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U (1989) Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579–592CrossRefPubMed
5.
Zurück zum Zitat Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRef Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRef
6.
Zurück zum Zitat Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T (2000) Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102(25):3137–3147CrossRef Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T (2000) Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102(25):3137–3147CrossRef
7.
Zurück zum Zitat Rollin J, Iochmann S, Blechet C, Hube F, Regina S, Guyetant S, Lemarie E, Reverdiau P, Gruel Y (2005) Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 92:775–783CrossRefPubMedPubMedCentral Rollin J, Iochmann S, Blechet C, Hube F, Regina S, Guyetant S, Lemarie E, Reverdiau P, Gruel Y (2005) Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 92:775–783CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res 128:179–185CrossRefPubMed Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res 128:179–185CrossRefPubMed
9.
Zurück zum Zitat Xu Z, Maiti D, Kisiel W, Duh EJ (2006) Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol 26:2819–2825CrossRefPubMed Xu Z, Maiti D, Kisiel W, Duh EJ (2006) Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol 26:2819–2825CrossRefPubMed
10.
Zurück zum Zitat Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C (2007) Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 27:310–316CrossRefPubMed Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C (2007) Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 27:310–316CrossRefPubMed
11.
Zurück zum Zitat Dong Y, Tan Q, Tao L, Pan X, Pang L, Liang W, Liu W, Zhang W, Li F, Jia W (2015) Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China. Int J Clin Exp Pathol 8(2):1844–1854PubMedPubMedCentral Dong Y, Tan Q, Tao L, Pan X, Pang L, Liang W, Liu W, Zhang W, Li F, Jia W (2015) Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China. Int J Clin Exp Pathol 8(2):1844–1854PubMedPubMedCentral
12.
Zurück zum Zitat Zhao BL, Liu HY, Ni HC, Luo X, Li J, Jin B, Zhu J, Li Y, Shen W, Shi H (2012) Changes of plasma tissue factor and tissue factor pathway inhibitor 2 levels in elderly patients with acute coronary syndrome. Shanghai Med 35:779–783 Zhao BL, Liu HY, Ni HC, Luo X, Li J, Jin B, Zhu J, Li Y, Shen W, Shi H (2012) Changes of plasma tissue factor and tissue factor pathway inhibitor 2 levels in elderly patients with acute coronary syndrome. Shanghai Med 35:779–783
13.
Zurück zum Zitat Yu J, Liu RL, Luo XP, Shi HM, Ma D, Pan JJ, Ni HC (2015) Tissue factor pathway inhibitor-2 gene polymorphisms associate with coronary atherosclerosis in Chinese population. Medicine (Baltimore) 94(42):e1675CrossRef Yu J, Liu RL, Luo XP, Shi HM, Ma D, Pan JJ, Ni HC (2015) Tissue factor pathway inhibitor-2 gene polymorphisms associate with coronary atherosclerosis in Chinese population. Medicine (Baltimore) 94(42):e1675CrossRef
14.
Zurück zum Zitat Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH, Tai CK (2015) DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics 10(3):229–236CrossRefPubMedPubMedCentral Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH, Tai CK (2015) DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics 10(3):229–236CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Arakawa N, Kobayashi H, Yonemoto N, Masuishi Y, Ino Y, Shigetomi H, Furukawa N, Ohtake N, Miyagi Y, Hirahara F, Hirano H, Miyagi E (2016) Clinical significance of tissue factor pathway inhibitor 2, a serum biomarker candidate for ovarian clear cell carcinoma. PLoS ONE 11(10):e0165609CrossRefPubMedPubMedCentral Arakawa N, Kobayashi H, Yonemoto N, Masuishi Y, Ino Y, Shigetomi H, Furukawa N, Ohtake N, Miyagi Y, Hirahara F, Hirano H, Miyagi E (2016) Clinical significance of tissue factor pathway inhibitor 2, a serum biomarker candidate for ovarian clear cell carcinoma. PLoS ONE 11(10):e0165609CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Pan JJ, Shi HM, Luo XP, Ma D, Li Y, Zhu J, Liang W, Mu JG, Li J (2011) Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL. Eur J Pharmacol 654:135–141CrossRefPubMed Pan JJ, Shi HM, Luo XP, Ma D, Li Y, Zhu J, Liang W, Mu JG, Li J (2011) Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL. Eur J Pharmacol 654:135–141CrossRefPubMed
18.
Zurück zum Zitat Pan J, Ma D, Sun F, Liang W, Liu R, Shen W, Wang H, Ji Y, Hu R, Liu R, Luo X, Shi H (2013) Over-expression of TFPI-2 promotes atherosclerotic plaque stability by inhibiting MMPs in apoE-/- mice. Int J Cardiol 168:1691–1697CrossRefPubMed Pan J, Ma D, Sun F, Liang W, Liu R, Shen W, Wang H, Ji Y, Hu R, Liu R, Luo X, Shi H (2013) Over-expression of TFPI-2 promotes atherosclerotic plaque stability by inhibiting MMPs in apoE-/- mice. Int J Cardiol 168:1691–1697CrossRefPubMed
19.
Zurück zum Zitat Siegling S, Thyzel E, Glahn J, Kleesiek K, Götting C (2006) Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann Hematol 85:32–37CrossRefPubMed Siegling S, Thyzel E, Glahn J, Kleesiek K, Götting C (2006) Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann Hematol 85:32–37CrossRefPubMed
20.
Zurück zum Zitat Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y (2003) Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb Res 109:207–215CrossRefPubMed Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y (2003) Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb Res 109:207–215CrossRefPubMed
21.
Zurück zum Zitat Mino K, Nishimura S, Ninomiya S, Tujii H, Matsumori Y, Tsuchida M, Hosoi M, Koseki K, Wada S, Hasegawa M, Sasaki R, Murakami-Yamaguchi Y, Narita H, Suzuki T, Miyata N, Mizukami T (2014) Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2). Biosci Biotechnol Biochem 78:1010–1017CrossRefPubMed Mino K, Nishimura S, Ninomiya S, Tujii H, Matsumori Y, Tsuchida M, Hosoi M, Koseki K, Wada S, Hasegawa M, Sasaki R, Murakami-Yamaguchi Y, Narita H, Suzuki T, Miyata N, Mizukami T (2014) Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2). Biosci Biotechnol Biochem 78:1010–1017CrossRefPubMed
22.
Zurück zum Zitat Zawadzki C, Chatelain N, Delestre M, Susen S, Quesnel B, Juthier F, Jeanpierre E, Azzaoui R, Corseaux D, Breyne J, Torpier G, Staels B, Van Belle E, Jude B (2009) Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 204:e4–e14CrossRefPubMed Zawadzki C, Chatelain N, Delestre M, Susen S, Quesnel B, Juthier F, Jeanpierre E, Azzaoui R, Corseaux D, Breyne J, Torpier G, Staels B, Van Belle E, Jude B (2009) Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 204:e4–e14CrossRefPubMed
23.
Zurück zum Zitat Kim JA, Chun EJ, Lee MS, Kim KJ, Choi SI (2013) Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging 29(Suppl 1):21–28CrossRefPubMed Kim JA, Chun EJ, Lee MS, Kim KJ, Choi SI (2013) Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging 29(Suppl 1):21–28CrossRefPubMed
24.
Zurück zum Zitat Jia EZ, Liang J, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ (2009) Smoking and coronary atherosclerosis: follow-up study in China. Clin Exp Pharmacol Physiol 36(7):690–695CrossRefPubMed Jia EZ, Liang J, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ (2009) Smoking and coronary atherosclerosis: follow-up study in China. Clin Exp Pharmacol Physiol 36(7):690–695CrossRefPubMed
Metadaten
Titel
Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han
verfasst von
Hairong Zhou
Yanjuan Che
Xiuhua Fu
Hong Wei
Xiuying Gao
Yanxuan Chen
Shaopeng Zhang
Publikationsdatum
20.10.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2019
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1755-6

Weitere Artikel der Ausgabe 1/2019

Journal of Thrombosis and Thrombolysis 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.